The impacts of corrected left ventricular ejection time combined with dobutamine on hepatocellular carcinoma patients.

Jian Y, Xiaochen J, Zongjian S, Yu N, Shiqiang S

Open source

DOI
10.1038/s41598-022-24907-x
Published
2022 Dec 7
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-022-24907-x,
  title = {The impacts of corrected left ventricular ejection time combined with dobutamine on hepatocellular carcinoma patients.},
  author = {Jian Y and Xiaochen J and Zongjian S and Yu N and Shiqiang S},
  year = {2022},
  journal = {Scientific reports},
  doi = {10.1038/s41598-022-24907-x},
  url = {https://doi.org/10.1038/s41598-022-24907-x}
}

RIS

TY  - JOUR
TI  - The impacts of corrected left ventricular ejection time combined with dobutamine on hepatocellular carcinoma patients.
AU  - Jian Y
AU  - Xiaochen J
AU  - Zongjian S
AU  - Yu N
AU  - Shiqiang S
PY  - 2022
JO  - Scientific reports
DO  - 10.1038/s41598-022-24907-x
UR  - https://doi.org/10.1038/s41598-022-24907-x
ER  - 

APA

Y, J., J, X., S, Z., N, Y., & S, S. (2022). The impacts of corrected left ventricular ejection time combined with dobutamine on hepatocellular carcinoma patients.. Scientific reports. https://doi.org/10.1038/s41598-022-24907-x

Source records